Quality-adjusted survival with combination nal-IRIFU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy : a Q-TWiST analysis

Authors :: Pelzer, Uwe
Blanc, Jean-Frédéric
Melisi, Davide
Cubillo, Antonio
Von Hoff, Daniel D.
Wang-Gillam, Andrea
Chen, Li-Tzong
Siveke, Jens
Wan, Yin
Solem, Caitlyn T.
Botteman, Marc F.
Yang, Yoojung
De Jong, Floris A.
Hubner, Richard A.
Publication Year :: 2017

Tools